skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Although both stocks are in the financial area but certainly quite different.
Both are moving quite significantly with renewed interest in the sector. Would either one or both be suitable buys, even with their current increase?
Thank you, Team!
Read Answer Asked by Sigrid on May 29, 2020
Q: Hi Peter & 5i,
Which of these 2 ETF's would you prefer and why, or if you have any other that is better, would be much appreciated. Thanks for your wonderful service. Stay safe. Ivan
Read Answer Asked by Ivan on May 28, 2020
Q: After the spinoff I am inclined to roll these three companies into one - if so, which one would you prefer ? Or, would be better to to sell all three and what would you suggest as a replacement ?? thanks, Jim
Read Answer Asked by jim on May 28, 2020
Q: Hello,
I wanted to get your thoughts (do you like the space) on Invitation Homes. Debt is on the higher side but it's an interesting concept that is meeting changing lifestyle demands by providing access to high-quality, updated homes with valued features such as close proximity to jobs and access to good schools.
Thank you,
Glen

Read Answer Asked by glen on May 28, 2020
Q: Hi 5i.
Thanks in advance love you guys! Recommend you to everyone I know. :) For RRSP if youcould buy one US stock which would it be?
I am well diversified, just have cash to dispence.
THansk P
Read Answer Asked by Paulette on May 28, 2020
Q: Hi 5i
What will Sanofi’s sale of its’ stake in Regeneron do to the price of regeneron? What is the $$ value and % of the REGN market cap? (about $12b?) Will Sanofi keep any of its regeneron interests). 5i pls look at the technicals and suggest an entry point? As the sale is to be completed by December (or the lock up) should one wait?
Many thanks,
Read Answer Asked by Kat on May 28, 2020
Q: Frontline is a shadow of its former self a decade ago. It has finally shown some signs of life in the last year: shows a 34% dividend. The fact that it actually still has a dividend seems remarkable.

Is this company buyable here? Is it better managed and is that dividend likely to continue. Was the dividend cut over the last 10 year or eliminated at all during this time/

Thanks for your insights here.
Read Answer Asked by Donald on May 28, 2020
Q: I want to buy two stocks from above selection. What would be your prefrence.
andrew.
Read Answer Asked by Andrzej on May 27, 2020
Q: I purchased AMGN - 18 months ago for $243.00. Since that time, it has come up to that level a year ago and recently twice this year. I have had the stock 18 months and I am still under water. 5i likes this stock in the health field - how much longer do you think it will take before I see a profit? On another note today the 26th - the market had the biggest run in ages, but participants (mostly tech) NVDA, PYPL, SHOP, KXS along with other techs, did not participate and went the other way. Were people selling these stocks to raise money to buy the other ones that went up? I know you will have the right answer. Thanks Dennis
Read Answer Asked by Dennis on May 27, 2020
Q: I plan to add initial positions in two of the following: Fortinet (FTNT), DocuSign (DOCU), Atlassian TEAM), or Veeva (VEEV). Would you please indicate their three year gain potential and risk. Thank You Paul
Read Answer Asked by Paul C. on May 27, 2020
Q: Due to Covid 19, more and more people are working from home and making purchases on line. Now team members are working remotely and need to collaborate effectively and securely, Please give your opinion about these companies, Anaplan (PLAN), Smartsheet (SMAR) and Absolute Software (ABT).

Thanks,
Read Answer Asked by vipin on May 27, 2020
Q: These two companies are slipping instead of going up if the
they have meaningful role in Covid.
AS well Jand J maybe having issue with product liability,
Appreciate your comments on the outlook going forward
Read Answer Asked by thambirajah on May 26, 2020
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!